The following Business Section contains forward-looking statements. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of certain risks, uncertainties and other factors including the risk factors set forth in Part I, Item 1A of this Annual Report on Form 10-K. In this report, Bio Green Med Solution, BGMS, the Company, we, us, and our refer to Bio Green Med Solution, Inc. ( fka Cyclacel Pharmaceuticals, Inc.). Recent Developments Equi...
Q2 FY2026 — expected 2026-09-12
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-30 | 2025-12-31 | 0001493152-26-013669 | EDGAR | 64K words |
| 2025-04-02 | 2024-12-31 | 0001558370-25-004331 | EDGAR | — |
| 2024-03-21 | 2023-12-31 | 0001558370-24-003713 | EDGAR | — |
| 2023-03-08 | 2022-12-31 | 0001558370-23-003163 | EDGAR | — |
| 2022-03-30 | 2021-12-31 | 0001558370-22-004769 | EDGAR | — |
| 2021-03-01 | 2020-12-31 | 0001558370-21-002093 | EDGAR | — |
| 2020-03-05 | 2019-12-31 | 0001558370-20-002077 | EDGAR | — |
| 2019-03-28 | 2018-12-31 | 0001144204-19-016652 | EDGAR | — |
| 2018-03-30 | 2017-12-31 | 0001571049-18-000206 | EDGAR | — |
| 2017-03-31 | 2016-12-31 | 0001571049-17-003095 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-13 | 2025-09-30 | 0001493152-25-022388 | EDGAR | 28K words |
| 2025-08-14 | 2025-06-30 | 0001641172-25-023648 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0001641172-25-010270 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0001558370-24-015349 | EDGAR | — |
| 2024-08-14 | 2024-06-30 | 0001558370-24-012271 | EDGAR | — |
| 2024-05-14 | 2024-03-31 | 0001558370-24-008159 | EDGAR | — |
| 2023-11-29 | 2023-09-30 | 0001558370-23-019370 | EDGAR | — |
| 2023-08-10 | 2023-06-30 | 0001558370-23-014533 | EDGAR | — |
| 2023-05-11 | 2023-03-31 | 0001558370-23-009443 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0001558370-22-017410 | EDGAR | — |
| 2022-08-11 | 2022-06-30 | 0001558370-22-013351 | EDGAR | — |
| 2022-05-12 | 2022-03-31 | 0001558370-22-008528 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-30 | 0001493152-26-013611 | EDGAR | 3K words |
| 2026-03-13 | 0001493152-26-009991 | EDGAR | — |
| 2026-01-12 | 0001493152-26-001848 | EDGAR | — |
| 2025-11-13 | 0001493152-25-022378 | EDGAR | — |
| 2025-11-06 | 0001493152-25-020920 | EDGAR | — |
| 2025-10-07 | 0001493152-25-017224 | EDGAR | — |
| 2025-10-07 | 0001493152-25-017223 | EDGAR | — |
| 2025-09-25 | 0001493152-25-014840 | EDGAR | — |
| 2025-09-16 | 0001493152-25-013703 | EDGAR | — |
| 2025-09-12 | 0001493152-25-013123 | EDGAR | — |
415 total filings indexed. 383 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001130166 |
| Ticker | BGMS |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://bgmsglobal.com |
| Listed | 2006-03-28 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report